Talk im Cube: IP Strategies in Biotechnology

17:00 till 19:00 o'clock
Save calendar entry
Berlin BioCube

BerlinBioCube (Building D95)

Campus Berlin-Buch

Robert-Rössle-Straße 10

13125 Berlin

We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology. Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding.

 

A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts are trained natural scientists AND European Patent Attorneys. With the upcoming talk they will share their insights and experiences with us.

A Panel Discussion with

  • Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich  
  • Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich
  • Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation). 
     

Topics planned to be addressed  

  • Smart patenting for Biotech: Portfolios providing leverage and attracting  investors
  • Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
  • Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries

…and much more.

The talk will be followed by a networking event where you can socialize over snacks and drinks.

Target audience 
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions. 

Costs
Participation is free of charge. Registration is requested. 

When 
Thursday, 18 September 2025
5:00 p.m. - 7:00 p.m.

Where 
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin 

Further information 

Further topic planned for 2025:
CROs in diagnostics and therapeutics development

 

Back